Chapter Text
Z-EXR-█████
“The Prisoner”
Z-EXR-█████, known on site as “Expendable” or “Prisoner”, is contained in heavy containment, known to be docile and compliant unlike previously contained Z-13. Z-EXR-█████ is generally quiet, not speaking to staff unless prompted for questioning or cognitive testing.
Z-EXR-█████ is relatively harmless, having learned their lesson after seeing the treatment of others who were not so lucky. Z-EXR-█████ is overseen by N.A.V.I., who takes pride in keeping her subjects in line. With this, Z-EXR-█████ poses no threat to staff, and can possibly be given rewards for their compliance to make sure that said compliance will continue on in the future. Such rewards can be giving them a Deep Sea Bunny, giving them requested food, and other accommodations, though minimal will be given due to cut costs. Generally, guardsman, science staff, and higher ups are only to be able to see Z-EXR-█████, with the remaining EXR-P at Hadal prohibited from even getting within a ██ stud radius of Z-EXR-█████.
Z-EXR-█████ was brought in as an EXR-P on October 16th, 2025. Z-EXR-█████ successfully collected Z-2 with the promise of being pardoned, but obviously said promise was never fulfilled. Z-EXR-█████ was in prison for ████████, before being brought in for the Expendable Protocol.
Around Dec 25, 2025, Z-EXR-█████ was selected to become a bioweapon for Urbanshade, as it was far easier and cheaper to collect DNA than to pay for construction of mechanical weapons. During this period, Z-EXR-█████ was given 0.6% of ████████ DNA, 0.3% of ████████ DNA, 0.9% of ████████ DNA, and other various aquatic life DNA. During the time of recovery, Z-EXR-█████ displayed physical symptoms of rejection, however staff was assured by N.A.V.I. that Z-EXR-█████ would live regardless of pain levels.
Z-EXR-█████ started to experience development as they had grown a tail, though it is noticeably smaller than Z-13’s. Z-EXR-█████ was given physical therapy to accomodate for their new features.
Z-EXR-█████ is to be ready for deployment by April 15, 2026.
